Andreas Voss

TL;DR: The number of surgical-site S. aureus infections acquired in the hospital can be reduced by rapid screening and decolonizing of nasal carriers of S.aureus on admission, a randomized, double-blind, placebo-controlled, multicenter trial.

TL;DR: S a Aureus nasal carriers and non-carriers differ significantly in risk and outcome of nosocomial S aureus bacteraemia.

TL;DR: A study among a group of 26 regional pig farmers to determine the methicillin-resistant Staphylococcus aureus prevalence rate found it was >760 times greater than the rate of patients admitted to Dutch hospitals.

TL;DR: In order to obtain pan-European data on methicillin-resistantStaphylococcus aureus (MRSA), 43 laboratories from 10 European countries each screened 200 consecutive Staphyloccus Aureus isolates for MRSA resistance only one isolate per patient was permitted All participants used a uniform oxacillin-supplemented screening plate and sent to Munich for reconfirmation and further susceptibility testing as mentioned in this paper.

TL;DR: In an ICU population in which the mortality rate associated with standard care was 27.5% at day 28, the rate was reduced by an estimated 3.5 percentage points with SDD and by 2.9 percentage pointsWith SOD, according to a random-effects logistic-regression model.